Fludrocortisone-A treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience
Pediatric Transplantation Jan 25, 2018
Ali SR, et al. - This study was performed to investigate the efficacy and safety of fludrocortisone treatment for tubulopathy in paediatric renal transplant patients. Researchers concluded that fludrocortisone was safe and effective for tubulopathies in children post-transplantation. Data did not reveal any side effects secondary to treatment with fludrocortisone.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries